Plain-English translation of NCT07914790 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing hydroxyethyl starch, a special fluid, to prevent a painful complication called post-dural puncture headache. This headache can develop after the membrane surrounding the spinal cord is accidentally punctured during epidural pain relief for labor or cesarean delivery. The study will compare women who receive injections of this medication into the epidural space with those who do not, to see if it reduces the chance of developing this type of headache.
When the membrane around the spinal cord is accidentally punctured during childbirth anesthesia, up to 80% of mothers develop a severe headache caused by fluid leaking from the spine. While current treatments exist, doctors want to find a way to prevent this headache from happening in the first place, rather than waiting to treat it after it develops.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to receive either the preventive fluid injection or standard care without the injection. If you receive the medication, it will be injected into your epidural space at specific times—either during your labor or after your cesarean delivery and again before the epidural catheter is removed. You will then be monitored to see whether you develop a headache over the following days, and researchers will track your recovery and any symptoms you experience.
AI-generated summary from trial data · Nov 14, 2026 · Not medical advice
China